Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Bexlutry™

(lutetium Lu 177 dotatate injection)

Active ingredient

Lutetium Lu 177 dotatate

Disease area

Oncology

Available in

Cisnaf®

CISNAF 100 MBq/mL solution for injection

Active ingredient

F18-sodium fluoride

Disease area

Oncology

Available in

Cisnaf® in France

Product information

Detectnet™

(copper Cu 64 dotatate injection)

Active ingredient

Copper Cu 64 dotatate

Disease area

Oncology

Available in

Dopacis®

Fluorodopa (18F) 90 MBq/mL solution for injection

Active ingredient

F18-fluorodopa

Disease area

Neurology, Oncology

Available in
, 

Dopacis® in Belgium

Product information
, 

Dopacis® in France

Product information
, 

Dopacis® in International

Product information
, 

Dopacis® in Italy

Product information
, 

Dopacis® in Luxembourg

Product information
, 

Dopacis® in Malta

Product information
, 

Dopacis® in Netherlands

Product information
, 

Dopacis® in Portugal

Product information
, 

Dopacis® in Slovenia

Product information

Dopacis® in Spain

Product information

ERtracER

ERtracER Solution for Injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

ERtracER in International

Product information
, 

ERtracER in Ireland

Product information

ERtracER in United Kingdom

Product information

Fludeomap

Fludeomap 250 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeomap in Estonia

Product information
, 

Fludeomap in Finland

Product information
, 

Fludeomap in Latvia

Product information
, 

Fludeomap in Lithuania

Product information
, 

Fludeomap in Norway

Product information

Fludeomap in Sweden

Product information

Fludeoxyglucose (18F)-Curium

Fludeoxyglucose (18F)-Curium 185 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F)-Curium in Austria

Product information
, 

Fludeoxyglucose (18F)-Curium in Belgium

Product information
, 

Fludeoxyglucose (18F)-Curium in France

Product information
, 

Fludeoxyglucose (18F)-Curium in International

Product information
, 

Fludeoxyglucose (18F)-Curium in Italy

Product information
, 

Fludeoxyglucose (18F)-Curium in Luxembourg

Product information
, 

Fludeoxyglucose (18F)-Curium in Malta

Product information
, 

Fludeoxyglucose (18F)-Curium in Netherlands

Product information
, 

Fludeoxyglucose (18F)-Curium in Portugal

Product information
, 

Fludeoxyglucose (18F)-Curium in Slovenia

Product information

Fludeoxyglucose (18F)-Curium in Spain

Product information

Fludeoxyglucose (18F)

Fludeoxyglucose (18F) Monrol 200-2200 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F) in Bulgaria

Product information
, 

Fludeoxyglucose (18F) in Greece

Product information

Fludeoxyglucose (18F) in Romania

Product information

Fluorocholine (18F)

Fluorocholine (18F) CIS bio international 225 MBq/mL solution for injection

Active ingredient

F18-fluorocholine

Disease area

Oncology

Available in
, 

Fluorocholine (18F) in Belgium

Product information
, 

Fluorocholine (18F) in France

Product information
, 

Fluorocholine (18F) in International

Product information
, 

Fluorocholine (18F) in Italy

Product information
, 

Fluorocholine (18F) in Luxembourg

Product information
, 

Fluorocholine (18F) in Malta

Product information
, 

Fluorocholine (18F) in Netherlands

Product information
, 

Fluorocholine (18F) in Portugal

Product information
, 

Fluorocholine (18F) in Slovenia

Product information

Fluorocholine (18F) in Spain

Product information

Gallium (67Ga) Citrate

Gallium Citrate Ga 67 Injection

Active ingredient

Gallium citrate Ga 67

Disease area

Infectious Diseases, Oncology, Pulmonology

Available in
, 

Gallium (67Ga) Citrate in Belgium

Product information
, 
, 

Gallium (67Ga) Citrate in Costa Rica

Product information
, 

Gallium (67Ga) Citrate in Czech Republic

Product information
, 

Gallium (67Ga) Citrate in Denmark

Product information
, 

Gallium (67Ga) Citrate in France

Product information
, 

Gallium (67Ga) Citrate in Greece

Product information
, 

Gallium (67Ga) Citrate in Hungary

Product information
, 

Gallium (67Ga) Citrate in International

Product information
, 

Gallium (67Ga) Citrate in Ireland

Product information
, 

Gallium (67Ga) Citrate in Italy

Product information
, 

Gallium (67Ga) Citrate in Netherlands

Product information
, 

Gallium (67Ga) Citrate in Portugal

Product information
, 

Gallium (67Ga) Citrate in Singapore

Product information
, 

Gallium (67Ga) Citrate in Spain

Product information
, 

Gallium (67Ga) Citrate in United Kingdom

Product information

Gallium (67Ga) Citrate in United States

Product information

GlucoTep

GlucoTep 150 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in

GlucoTep in France

Product information

Indium (111In) Chloride

Indium (111In) Chloride Curiumpharma 370 MBq/ml radiopharmaceutical precursor

Active ingredient

In111-chloride

Disease area

Infectious Diseases, Oncology

Available in
, 

Indium (111In) Chloride in Belgium

Product information
, 

Indium (111In) Chloride in Czech Republic

Product information
, 

Indium (111In) Chloride in Denmark

Product information
, 

Indium (111In) Chloride in Finland

Product information
, 

Indium (111In) Chloride in France

Product information
, 

Indium (111In) Chloride in Greece

Product information
, 

Indium (111In) Chloride in Ireland

Product information
, 

Indium (111In) Chloride in Netherlands

Product information
, 

Indium (111In) Chloride in Norway

Product information
, 

Indium (111In) Chloride in Singapore

Product information
, 

Indium (111In) Chloride in Spain

Product information
, 

Indium (111In) Chloride in Sweden

Product information
, 

Indium (111In) Chloride in Switzerland

Product information

Indium (111In) Chloride in United Kingdom

Product information

Kit for the Preparation of Technetium Tc99m Sestamibi Injection

Tc 99m Sestamibi Injection

Active ingredient

Cu MIBI

Disease area

Cardiology, Oncology

Available in
, 

Kit for the Preparation of Technetium Tc99m Sestamibi Injection in Canada

Product information

Kit for the Preparation of Technetium Tc99m Sestamibi Injection in United States

Product information

Lutetium-177 chloride

Lutetium (¹⁷⁷Lu) chloride 40 GBq/mL radiopharmaceutical precursor

Active ingredient

Lutetium (¹⁷⁷Lu) chloride

Disease area

Oncology

Available in
, 

Lutetium-177 chloride in Austria

Product information
, 

Lutetium-177 chloride in Belgium

Product information
, 

Lutetium-177 chloride in France

Product information
, 

Lutetium-177 chloride in Germany

Product information
, 

Lutetium-177 chloride in Italy

Product information
, 

Lutetium-177 chloride in Netherlands

Product information
, 

Lutetium-177 chloride in Portugal

Product information
, 

Lutetium-177 chloride in Spain

Product information

Lutetium-177 chloride in Sweden

Product information

MIBG (I123)

MIBG (123.I) 74 MBq/mL solution for injection

Active ingredient

Iobenguane

Disease area

Oncology

Available in
, 

MIBG (I123) in Belgium

Product information
, 

MIBG (I123) in Czech Republic

Product information
, 

MIBG (I123) in Denmark

Product information
, 

MIBG (I123) in Finland

Product information
, 

MIBG (I123) in France

Product information
, 

MIBG (I123) in Germany

Product information
, 

MIBG (I123) in Hungary

Product information
, 

MIBG (I123) in Ireland

Product information
, 

MIBG (I123) in Italy

Product information
, 

MIBG (I123) in Netherlands

Product information
, 

MIBG (I123) in Norway

Product information
, 

MIBG (I123) in Slovakia

Product information
, 

MIBG (I123) in Spain

Product information
, 

MIBG (I123) in Sweden

Product information
, 

MIBG (I123) in Switzerland

Product information

MIBG (I123) in United Kingdom

Product information

Norchol-131

Norchol-131, 7,5 - 15 MBq/mL solution for injection

Active ingredient

Iodomethyl norcholesterol (131I)

Disease area

Nephrology, Oncology

Available in
, 

Norchol-131 in France

Product information
, 

Norchol-131 in International

Product information
, 

Norchol-131 in Italy

Product information

Norchol-131 in Spain

Product information

Octreoscan™

(kit for the preparation of indium In 111 pentetreotide injection)

Active ingredient

In111-pentetreotide

Disease area

Oncology

Available in
, 

Octreoscan™ in Austria

Product information
, 

Octreoscan™ in Belgium

Product information
, 

Octreoscan™ in Czech Republic

Product information
, 

Octreoscan™ in Denmark

Product information
, 

Octreoscan™ in France

Product information
, 

Octreoscan™ in Germany

Product information
, 

Octreoscan™ in Greece

Product information
, 

Octreoscan™ in Hungary

Product information
, 

Octreoscan™ in International

Product information
, 

Octreoscan™ in Ireland

Product information
, 

Octreoscan™ in Italy

Product information
, 

Octreoscan™ in Mexico

Product information
, 

Octreoscan™ in Netherlands

Product information
, 

Octreoscan™ in Portugal

Product information
, 

Octreoscan™ in Republic of Korea

Product information
, 

Octreoscan™ in Singapore

Product information
, 

Octreoscan™ in Slovakia

Product information
, 

Octreoscan™ in Spain

Product information
, 

Octreoscan™ in Sweden

Product information
, 

Octreoscan™ in United Kingdom

Product information

Octreoscan™ in United States

Product information

ProstaTep

ProstaTep, 500 MBq/mL, solution for injection

Active ingredient

F18-fluorocholine

Disease area

Endocrinology, Oncology

Available in

ProstaTep in France

Product information

PYLCLARI®

PYLCLARI®

Active ingredient

Piflufolastat (18F)

Disease area

Oncology

Available in
, 

PYLCLARI® in Austria

Product information
, 

PYLCLARI® in Bulgaria

Product information
, 

PYLCLARI® in Croatia

Product information
, 

PYLCLARI® in Czech Republic

Product information
, 

PYLCLARI® in Denmark

Product information
, 

PYLCLARI® in Estonia

Product information
, 

PYLCLARI® in Finland

Product information
, 

PYLCLARI® in France

Product information
, 

PYLCLARI® in Germany

Product information
, 

PYLCLARI® in Greece

Product information
, 

PYLCLARI® in Hungary

Product information
, 

PYLCLARI® in Iceland

Product information
, 

PYLCLARI® in Italy

Product information
, 

PYLCLARI® in Latvia

Product information
, 

PYLCLARI® in Lithuania

Product information
, 

PYLCLARI® in Malta

Product information
, 

PYLCLARI® in Netherlands

Product information
, 

PYLCLARI® in Norway

Product information
, 

PYLCLARI® in Poland

Product information
, 

PYLCLARI® in Portugal

Product information
, 

PYLCLARI® in Romania

Product information
, 

PYLCLARI® in Slovakia

Product information
, 

PYLCLARI® in Slovenia

Product information
, 

PYLCLARI® in Spain

Product information

PYLCLARI® in Sweden

Product information

Quadramet®

Quadramet, 1.3 GBq/mL solution for injection

Active ingredient

Sm153-lexidronam

Disease area

Oncology

Available in
, 

Quadramet® in Austria

Product information
, 

Quadramet® in Belgium

Product information
, 

Quadramet® in Bulgaria

Product information
, 

Quadramet® in Croatia

Product information
, 

Quadramet® in Cyprus

Product information
, 

Quadramet® in Czech Republic

Product information
, 

Quadramet® in Denmark

Product information
, 

Quadramet® in Estonia

Product information
, 

Quadramet® in Finland

Product information
, 

Quadramet® in France

Product information
, 

Quadramet® in Germany

Product information
, 

Quadramet® in Greece

Product information
, 

Quadramet® in Hungary

Product information
, 

Quadramet® in Iceland

Product information
, 

Quadramet® in International

Product information
, 

Quadramet® in Ireland

Product information
, 

Quadramet® in Italy

Product information
, 

Quadramet® in Latvia

Product information
, 

Quadramet® in Lithuania

Product information
, 

Quadramet® in Luxembourg

Product information
, 

Quadramet® in Malta

Product information
, 

Quadramet® in Mexico

Product information
, 

Quadramet® in Netherlands

Product information
, 

Quadramet® in Norway

Product information
, 

Quadramet® in Poland

Product information
, 

Quadramet® in Portugal

Product information
, 

Quadramet® in Romania

Product information
, 

Quadramet® in Slovakia

Product information
, 

Quadramet® in Slovenia

Product information
, 

Quadramet® in Spain

Product information
, 

Quadramet® in Sweden

Product information

Quadramet® in United Kingdom

Product information

Sodium iodide (¹³¹I)

MONIYOT-131 Capsule T 37-7400 MBq hard capsule for therapeutic use

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) in Denmark

Product information
, 

Sodium iodide (¹³¹I) in Germany

Product information
, 

Sodium iodide (¹³¹I) in Greece

Product information

Sodium iodide (¹³¹I) in Romania

Product information

Sodium iodide (¹³¹I) – oral solution

MONIYOT-131 14.8–3700 MBq/mL oral solution

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium iodide (¹³¹I) – oral solution in Bulgaria

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Denmark

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Germany

Product information
, 

Sodium iodide (¹³¹I) – oral solution in Greece

Product information

Sodium iodide (¹³¹I) – oral solution in Romania

Product information

Sodium Iodide I-131 Capsules Therapeutic

Sodium Iodide (131I) Capsules T 37-7400 MBq/mL hard capsule

Active ingredient

Sodium iodide (¹³¹I)

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I-131 Capsules Therapeutic in Austria

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Belgium

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Bosnia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Colombia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Costa Rica

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Czech Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Denmark

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Dominican Republic

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Finland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in France

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Germany

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Hungary

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Ireland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Italy

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Mexico

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Netherlands

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Norway

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Peru

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Portugal

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Serbia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Slovakia

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Spain

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Sweden

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Switzerland

Product information
, 

Sodium Iodide I-131 Capsules Therapeutic in Turkey

Product information

Sodium Iodide I-131 Capsules Therapeutic in United Kingdom

Product information

Sodium Iodide I123 Injection

Sodium iodide (123I) 37 MBq/mL solution for injection

Active ingredient

I123-sodium

Disease area

Endocrinology, Oncology

Available in
, 

Sodium Iodide I123 Injection in Belgium

Product information
, 

Sodium Iodide I123 Injection in Czech Republic

Product information
, 

Sodium Iodide I123 Injection in Denmark

Product information
, 

Sodium Iodide I123 Injection in Finland

Product information
, 

Sodium Iodide I123 Injection in France

Product information
, 

Sodium Iodide I123 Injection in Germany

Product information
, 

Sodium Iodide I123 Injection in Hungary

Product information
, 

Sodium Iodide I123 Injection in Italy

Product information
, 

Sodium Iodide I123 Injection in Netherlands

Product information
, 

Sodium Iodide I123 Injection in Norway

Product information
, 

Sodium Iodide I123 Injection in Spain

Product information
, 

Sodium Iodide I123 Injection in Sweden

Product information
, 

Sodium Iodide I123 Injection in Switzerland

Product information

Sodium Iodide I123 Injection in United Kingdom

Product information

Teceos®

Teceos 13 mg kit for radiopharmaceutical preparation

Active ingredient

Butedronate tetrasodium

Disease area

Cardiology, Oncology

Available in
, 

Teceos® in Austria

Product information
, 

Teceos® in Denmark

Product information
, 

Teceos® in Finland

Product information
, 

Teceos® in France

Product information
, 

Teceos® in Germany

Product information
, 

Teceos® in Greece

Product information
, 

Teceos® in International

Product information
, 

Teceos® in Mexico

Product information
, 

Teceos® in Netherlands

Product information
, 

Teceos® in Norway

Product information
, 

Teceos® in Republic of Korea

Product information
, 

Teceos® in Spain

Product information
, 

Teceos® in Sweden

Product information

Teceos® in Switzerland

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information